Over 825.7 mn coronavirus vaccine doses given to states, UTs so far: Govt

More than 82.57 crore Covid vaccine doses have been provided to states and union territories so far and over 94 lakh doses are in the pipeline, the Union Health Ministry said on Saturday.

A medic gives a Covid-19 vaccine dose to a woman at the state-run Civil Hospital in Lucknow, on September 9, 2021. (PTI Photo/ Nand Kumar)
A medic gives a Covid-19 vaccine dose to a woman at the state-run Civil Hospital in Lucknow, on September 9, 2021. (PTI Photo/ Nand Kumar)
Press Trust of India New Delhi
2 min read Last Updated : Sep 25 2021 | 1:03 PM IST

More than 82.57 crore Covid vaccine doses have been provided to states and union territories so far and over 94 lakh doses are in the pipeline, the Union Health Ministry said on Saturday.

Over 4.15 crore balance and unutilised vaccine doses are still available with the states and the union territories for inoculation, it said.

The Union government is committed to accelerating the pace and expanding the scope of Covid vaccination throughout the country, the ministry said in a statement.

"More than 82.57 crore (82,57,88,115) vaccine doses have been provided to states/UTs so far through the government of India (free of cost channel) and through direct state procurement category. Further, more than 94 lakh doses (94,37,525) are in the pipeline," it said.

The inoculation drive has been ramped up through the availability of more vaccines, advance visibility of vaccine availability to states and union territories for enabling better planning by them and streamlining the vaccine supply chain, it added.

As part of the nationwide vaccination drive, the Centre has been supporting the states and union territories by providing them Covid vaccines free of cost, the statement said.

Under the universalisation of the Covid vaccination drive, the central government procures and supplies free of cost 75 percent of the vaccines being produced by vaccine manufacturers in the country to states and union territories.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: Sep 25 2021 | 1:03 PM IST

Next Story